The role of complement factor C3 in lipid metabolism

Molecular Immunology

Volumn 67, Issue 1, 2015, Pages 101-107

  Barbu, Andreea ^a   Hamad, Osama A ^a   Lind, Lars ^a   Ekdahl, Kristina N ^a   Nilsson, Bo ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Apolipoproteins; C3; C3a desArg; Metabolic syndrome (MetS); Obesity

Indexed keywords

COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C3 RECEPTOR; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C5A; COMPLEMENT COMPONENT C5A RECEPTOR; LIPOPROTEIN; APOLIPOPROTEIN; COMPLEMENT C3A, DES-ARG-(77)-; COMPLEMENT RECEPTOR; TRIACYLGLYCEROL;

ADIPOCYTE; ADIPOSE TISSUE; COMPLEMENT ACTIVATION; COMPLEMENT BLOOD LEVEL; HUMAN; INFLAMMATION; INSULIN RESISTANCE; INTESTINE; LIPID METABOLISM; MACROPHAGE; METABOLIC SYNDROME X; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REVIEW; CARDIOVASCULAR DISEASE; DIABETES MELLITUS; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; METABOLISM; PATHOLOGY; RISK FACTOR;

ADIPOSE TISSUE; APOLIPOPROTEINS; CARDIOVASCULAR DISEASES; COMPLEMENT C3A; COMPLEMENT C5A; DIABETES MELLITUS; GENE EXPRESSION REGULATION; HUMANS; INSULIN RESISTANCE; LIPID METABOLISM; METABOLIC SYNDROME X; OBESITY; RECEPTORS, COMPLEMENT; RISK FACTORS; TRIGLYCERIDES;

EID: 84936985678     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2015.02.027     Document Type: Review

References (90)

1. Ahren B., Havel P.J., Pacini G., Cianflone K. Acylation stimulating protein stimulates insulin secretion. Int. J. Obes. Relat. Metab. Disord.: J. Int. Assoc. Study Obes. 2003, 27:1037-1043.
2. Ailhaud G., Grimaldi P., Negrel R. Cellular and molecular aspects of adipose tissue development. Annu. Rev. Nutr. 1992, 12:207-233.
3. Alwaili K., Bailey D., Awan Z., Bailey S.D., Ruel I., Hafiane A., Krimbou L., Laboissiere S., Genest J. The HDL proteome in acute coronary syndromes shifts to an inflammatory profile. Biochim. Biophys. Acta 2012, 1821:405-415.
4. Artero E.G., Espana-Romero V., Jimenez-Pavon D., Martinez-Gomez D., Warnberg J., Gomez-Martinez S., Gonzalez-Gross M., Vanhelst J., Kafatos A., Molnar D., De Henauw S., Moreno L.A., Marcos A., Castillo M.J. Muscular fitness, fatness and inflammatory biomarkers in adolescents. Pediatr. Obes. 2014, 9:391-400. HELENA study group.
5. Baldo A., Sniderman A.D., St-Luce S., Avramoglu R.K., Maslowska M., Hoang B., Monge J.C., Bell A., Mulay S., Cianflone K. The adipsin-acylation stimulating protein system and regulation of intracellular triglyceride synthesis. J. Clin. Investig. 1993, 92:1543-1547.
6. Bamberg C.E., Mackay C.R., Lee H., Zahra D., Jackson J., Lim Y.S., Whitfeld P.L., Craig S., Corsini E., Lu B., Gerard C., Gerard N.P. The C5a receptor (C5aR) C5L2 is a modulator of C5aR-mediated signal transduction. J. Biol. Chem. 2010, 285:7633-7644.
7. Benacerraf B., Sebestyen M.M., Schlossman S. A quantitative study of the kinetics of blood clearance of P32-labelled Escherichia coli and Staphylococci by the reticuloendothelial system. J. Exp. Med. 1959, 110:27-48.
8. Buchner R.R., Hugli T.E., Ember J.A., Morgan E.L. Expression of functional receptors for human C5a anaphylatoxin (CD88) on the human hepatocellular carcinoma cell line HepG2. Stimulation of acute-phase protein-specific mRNA and protein synthesis by human C5a anaphylatoxin. J. Immunol. 1995, 155:308-315.
9. Caro J.F., Sinha M.K., Kolaczynski J.W., Zhang P.L., Considine R.V. Leptin: the tale of an obesity gene. Diabetes 1996, 45:1455-1462.
10. Chen N.J., Mirtsos C., Suh D., Lu Y.C., Lin W.J., McKerlie C., Lee T., Baribault H., Tian H., Yeh W.C. C5L2 is critical for the biological activities of the anaphylatoxins C5a and C3a. Nature 2007, 446:203-207.
11. Choy L.N., Rosen B.S., Spiegelman B.M. Adipsin and an endogenous pathway of complement from adipose cells. J. Biol. Chem. 1992, 267:12736-12741.
12. Cianflone K., Maslowska M. Differentiation-induced production of ASP in human adipocytes. Eur. J. Clin. Invest. 1995, 25:817-825.
13. Cianflone K.M., Sniderman A.D., Walsh M.J., Vu H.T., Gagnon J., Rodriguez M.A. Purification and characterization of acylation stimulating protein. J. Biol. Chem. 1989, 264:426-430.
14. Cui W., Simaan M., Laporte S., Lodge R., Cianflone K. C5a- and ASP-mediated C5L2 activation, endocytosis and recycling are lost in S323I-C5L2 mutation. Mol. Immunol. 2009, 46:3086-3098.
15. Das D., Barnes M.A., Nagy L.E. Anaphylatoxin C5a modulates hepatic stellate cell migration. Fibrogen. Tissue Repair 2014, 7:9.
16. Daveau M., Benard M., Scotte M., Schouft M.T., Hiron M., Francois A., Salier J.P., Fontaine M. Expression of a functional C5a receptor in regenerating hepatocytes and its involvement in a proliferative signaling pathway in rat. J. Immunol. 2004, 173:3418-3424.
17. Dufaux B., Order U. Complement activation after prolonged exercise. Clin. Chim. Acta: Int. J. Clin. Chem. 1989, 179:45-49.
18. Engstrom G., Hedblad B., Eriksson K.F., Janzon L., Lindgarde F. Complement C3 is a risk factor for the development of diabetes: a population-based cohort study. Diabetes 2005, 54:570-575.
19. Fujita T., Fujioka T., Murakami T., Satomura A., Fuke Y., Matsumoto K. Chylomicron accelerates C3 tick-over by regulating the role of factor H, leading to overproduction of acylation stimulating protein. J. Clin. Lab. Anal. 2007, 21:14-23.
20. Gardinali M., Conciato L., Cafaro C., Crosignani A., Battezzati P.M., Agostoni A., Podda M. Complement system is not activated in primary biliary cirrhosis. Clin. Immunol. Immunopathol. 1998, 87:297-303.
21. Hinglais N., Kazatchkine M.D., Mandet C., Appay M.D., Bariety J. Human liver Kupffer cells express CR1, CR3, and CR4 complement receptor antigens. An immunohistochemical study. Lab. Investig.: J. Techn. Methods Pathol. 1989, 61:509-514.
22. Hollman D.A., Milona A., van Erpecum K.J., van Mil S.W. Anti-inflammatory and metabolic actions of FXR: insights into molecular mechanisms. Biochim. Biophys. Acta 2012, 1821:1443-1452.
23. Hotamisligil G.S., Shargill N.S., Spiegelman B.M. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993, 259:87-91.
24. Hotamisligil G.S., Spiegelman B.M. Tumor necrosis factor alpha: a key component of the obesity-diabetes link. Diabetes 1994, 43:1271-1278.
25. Jones E.A., Vergalla J., Steer C.J., Bradley-Moore P.R., Vierling J.M. Metabolism of intact and desialylated alpha 1-antitrypsin. Clin. Sci. Mol. Med. 1978, 55:139-148.
26. Kalant D., Cain S.A., Maslowska M., Sniderman A.D., Cianflone K., Monk P.N. The chemoattractant receptor-like protein C5L2 binds the C3a des-Arg77/acylation-stimulating protein. J. Biol. Chem. 2003, 278:11123-11129.
27. Klos A., Tenner A.J., Johswich K.O., Ager R.R., Reis E.S., Kohl J. The role of the anaphylatoxins in health and disease. Mol. Immunol. 2009, 46:2753-2766.
28. Koistinen H.A., Vidal H., Karonen S.L., Dusserre E., Vallier P., Koivisto V.A., Ebeling P. Plasma acylation stimulating protein concentration and subcutaneous adipose tissue C3 mRNA expression in nondiabetic and type 2 diabetic men. Arterioscler. Thromb. Vasc. Biol. 2001, 21:1034-1039.
29. Koleva M., Schlaf G., Landmann R., Gotze O., Jungermann K., Schieferdecker H.L. Induction of anaphylatoxin C5a receptors in rat hepatocytes by lipopolysaccharide in vivo: mediation by interleukin-6 from Kupffer cells. Gastroenterology 2002, 122:697-708.
30. Li J., Pircher P.C., Schulman I.G., Westin S.K. Regulation of complement C3 expression by the bile acid receptor FXR. J. Biol. Chem. 2005, 280:7427-7434.
31. Lim J., Iyer A., Suen J.Y., Seow V., Reid R.C., Brown L., Fairlie D.P. C5aR and C3aR antagonists each inhibit diet-induced obesity, metabolic dysfunction, and adipocyte and macrophage signaling. FASEB J.: Off. Publ. Fed. Am. Soc. Exp. Biol. 2013, 27:822-831.
32. Liu Y., Gupta P., Lapointe M., Yotsapon T., Sarat S., Cianflone K. Acylation stimulating protein, complement C3 and lipid metabolism in ketosis-prone diabetic subjects. PLOS ONE 2014, 9:e109237.
33. Lo J.C., Ljubicic S., Leibiger B., Kern M., Leibiger I.B., Moede T., Kelly M.E., Chatterjee Bhowmick D., Murano I., Cohen P., Banks A.S., Khandekar M.J., Dietrich A., Flier J.S., Cinti S., Bluher M., Danial N.N., Berggren P.O., Spiegelman B.M. Adipsin is an adipokine that improves beta cell function in diabetes. Cell 2014, 158:41-53.
34. Maeda K., Okubo K., Shimomura I., Funahashi T., Matsuzawa Y., Matsubara K. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). Biochem. Biophys. Res. Commun. 1996, 221:286-289.
35. Makki K., Froguel P., Wolowczuk I. Adipose tissue in obesity-related inflammation and insulin resistance: cells, cytokines, and chemokines. ISRN Inflamm. 2013, 2013:139239.
36. Mamane Y., Chung Chan C., Lavallee G., Morin N., Xu L.J., Huang J., Gordon R., Thomas W., Lamb J., Schadt E.E., Kennedy B.P., Mancini J.A. The C3a anaphylatoxin receptor is a key mediator of insulin resistance and functions by modulating adipose tissue macrophage infiltration and activation. Diabetes 2009, 58:2006-2017.
37. Maslowska M., Legakis H., Assadi F., Cianflone K. Targeting the signaling pathway of acylation stimulating protein. J. Lipid Res. 2006, 47:643-652.
38. Maslowska M., Vu H., Phelis S., Sniderman A.D., Rhode B.M., Blank D., Cianflone K. Plasma acylation stimulating protein, adipsin and lipids in non-obese and obese populations. Eur. J. Clin. Invest. 1999, 29:679-686.
39. Maslowska M., Wang H.W., Cianflone K. Novel roles for acylation stimulating protein/C3adesArg: a review of recent in vitro and in vivo evidence. Vitam. Horm. 2005, 70:309-332.
40. Mazumdar B., Kim H., Meyer K., Bose S.K., Di Bisceglie A.M., Ray R.B., Ray R. Hepatitis C virus proteins inhibit C3 complement production. J. Virol. 2012, 86:2221-2228.
41. Mogilenko D.A., Kudriavtsev I.V., Trulioff A.S., Shavva V.S., Dizhe E.B., Missyul B.V., Zhakhov A.V., Ischenko A.M., Perevozchikov A.P., Orlov S.V. Modified low density lipoprotein stimulates complement C3 expression and secretion via liver X receptor and Toll-like receptor 4 activation in human macrophages. J. Biol. Chem. 2012, 287:5954-5968.
42. Mohamed-Ali V., Goodrick S., Rawesh A., Katz D.R., Miles J.M., Yudkin J.S., Klein S., Coppack S.W. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J. Clin. Endocrinol. Metab. 1997, 82:4196-4200.
43. Monk P.N., Scola A.M., Madala P., Fairlie D.P. Function, structure and therapeutic potential of complement C5a receptors. Br. J. Pharmacol. 2007, 152:429-448.
44. Murray I., Havel P.J., Sniderman A.D., Cianflone K. Reduced body weight, adipose tissue, and leptin levels despite increased energy intake in female mice lacking acylation-stimulating protein. Endocrinology 2000, 141:1041-1049.
45. Murray I., Sniderman A.D., Cianflone K. Mice lacking acylation stimulating protein (ASP) have delayed postprandial triglyceride clearance. J. Lipid Res. 1999, 40:1671-1676.
46. Muscari A., Bozzoli C., Puddu G.M., Rovinetti C., Fiorentini G.P., Roversi R.A., Puddu P. Correlations between serum lipids and complement components in adults without demonstrated atherosclerotic disease. Atherosclerosis 1990, 81:111-118.
47. Nicol P.A., Lachmann P.J. The alternate pathway of complement activation. The role of C3 and its inactivator (KAF). Immunology 1973, 24:259-275.
48. Nilsson B., Ekdahl K.N. Complement diagnostics: concepts, indications, and practical guidelines. Clin. Dev. Immunol. 2012, 2012. 962702.
49. Nilsson B., Hamad O.A., Ahlstrom H., Kullberg J., Johansson L., Lindhagen L., Haenni A., Ekdahl K.N., Lind L. C3 and C4 are strongly related to adipose tissue variables and cardiovascular risk factors. Eur. J. Clin. Invest. 2014, 44:587-596.
50. Norda R., Schott U., Berseus O., Akerblom O., Nilsson B., Ekdahl K.N., Stegmayr B.G., Knutson F. Complement activation products in liquid stored plasma and C3a kinetics after transfusion of autologous plasma. Vox Sang. 2012, 102:125-133.
51. Okamoto M., Ohara-Imaizumi M., Kubota N., Hashimoto S., Eto K., Kanno T., Kubota T., Wakui M., Nagai R., Noda M., Nagamatsu S., Kadowaki T. Adiponectin induces insulin secretion in vitro and in vivo at a low glucose concentration. Diabetologia 2008, 51:827-835.
52. Okinaga S., Slattery D., Humbles A., Zsengeller Z., Morteau O., Kinrade M.B., Brodbeck R.M., Krause J.E., Choe H.R., Gerard N.P., Gerard C. C5L2, a nonsignaling C5A binding protein. Biochemistry 2003, 42:9406-9415.
53. Oktenli C., Ozgurtas T., Dede M., Sanisoglu Y.S., Yenen M.C., Yesilova Z., Kenar L., Kurt Y.G., Baser I., Smith J., Cianflone K. Metformin decreases circulating acylation-stimulating protein levels in polycystic ovary syndrome. Gynecol. Endocrinol.: Off. J. Int. Soc. Gynecol. Endocrinol. 2007, 23:710-715.
54. Onat A., Can G., Rezvani R., Cianflone K. Complement C3 and cleavage products in cardiometabolic risk. Clin. Chim. Acta 2011, 412:1171-1179.
55. Onat A., Hergenc G., Can G., Kaya Z., Yuksel H. Serum complement C3: a determinant of cardiometabolic risk, additive to the metabolic syndrome, in middle-aged population. Metabolism. 2010, 59:628-634.
56. Ouchi N., Parker J.L., Lugus J.J., Walsh K. Adipokines in inflammation and metabolic disease. Nat. Rev. Immunol. 2011, 11:85-97.
57. Ozata M., Gungor D., Turan M., Ozisik G., Bingol N., Ozgurtas T., Ozdemir I.C. Improved glycemic control increases fasting plasma acylation-stimulating protein and decreases leptin concentrations in type II diabetic subjects. J. Clin. Endocrinol. Metab. 2001, 86:3659-3664.
58. Paglialunga S., Schrauwen P., Roy C., Moonen-Kornips E., Lu H., Hesselink M.K., Deshaies Y., Richard D., Cianflone K. Reduced adipose tissue triglyceride synthesis and increased muscle fatty acid oxidation in C5L2 knockout mice. J. Endocrinol. 2007, 194:293-304.
59. Palikhe A., Sinisalo J., Seppanen M., Haario H., Meri S., Valtonen V., Nieminen M.S., Lokki M.L. Serum complement C3/C4 ratio, a novel marker for recurrent cardiovascular events. Am. J. Cardiol. 2007, 99:890-895.
60. Pattrick M., Luckett J., Yue L., Stover C. Dual role of complement in adipose tissue. Mol. Immunol. 2009, 46:755-760.
61. Peake P.W., O'Grady S., Pussell B.A., Charlesworth J.A. Detection and quantification of the control proteins of the alternative pathway of complement in 3T3-L1 adipocytes. Eur. J. Clin. Invest. 1997, 27:922-927.
62. Phieler J., Chung K.J., Chatzigeorgiou A., Klotzsche-von Ameln A., Garcia-Martin R., Sprott D., Moisidou M., Tzanavari T., Ludwig B., Baraban E., Ehrhart-Bornstein M., Bornstein S.R., Mziaut H., Solimena M., Karalis K.P., Economopoulou M., Lambris J.D., Chavakis T. The complement anaphylatoxin C5a receptor contributes to obese adipose tissue inflammation and insulin resistance. J. Immunol. 2013, 191:4367-4374.
63. Phieler J., Garcia-Martin R., Lambris J.D., Chavakis T. The role of the complement system in metabolic organs and metabolic diseases. Semin. Immunol. 2013, 25:47-53.
64. Poursharifi P., Lapointe M., Fisette A., Lu H., Roy C., Munkonda M.N., Fairlie D.P., Cianflone K. C5aR and C5L2 act in concert to balance immunometabolism in adipose tissue. Molecular and cellular endocrinology 2014, 382:325-333.
65. Poursharifi P., Lapointe M., Petrin D., Devost D., Gauvreau D., Hebert T.E., Cianflone K. C5L2 and C5aR interaction in adipocytes and macrophages: insights into adipoimmunology. Cell. Signal. 2013, 25:910-918.
66. Qin X., Gao B. The complement system in liver diseases. Cell. Mol. Immunol. 2006, 3:333-340.
67. Ricklin D., Hajishengallis G., Yang K., Lambris J.D. Complement: a key system for immune surveillance and homeostasis. Nat. Immunol. 2010, 11:785-797.
68. Samad F., Ruf W. Inflammation, obesity, and thrombosis. Blood 2013, 122:3415-3422.
69. Scantlebury T., Maslowska M., Cianflone K. Chylomicron-specific enhancement of acylation stimulating protein and precursor protein C3 production in differentiated human adipocytes. J. Biol. Chem. 1998, 273:20903-20909.
70. Schadt E.E., Lamb J., Yang X., Zhu J., Edwards S., Guhathakurta D., Sieberts S.K., Monks S., Reitman M., Zhang C., Lum P.Y., Leonardson A., Thieringer R., Metzger J.M., Yang L., Castle J., Zhu H., Kash S.F., Drake T.A., Sachs A., Lusis A.J. An integrative genomics approach to infer causal associations between gene expression and disease. Nat. Genet. 2005, 37:710-717.
71. Schieferdecker H.L., Rothermel E., Timmermann A., Gotze O., Jungermann K. Anaphylatoxin C5a receptor mRNA is strongly expressed in Kupffer and stellate cells and weakly in sinusoidal endothelial cells but not in hepatocytes of normal rat liver. FEBS Lett. 1997, 406:305-309.
72. Schlaf G., Schmitz M., Heine I., Demberg T., Schieferdecker H.L., Gotze O. Upregulation of fibronectin but not of entactin, collagen IV and smooth muscle actin by anaphylatoxin C5a in rat hepatic stellate cells. Histology and histopathology 2004, 19:1165-1174.
73. Sliwinski A.J., Zvaifler N.J. Decreased synthesis of the third component of complement (C3) in hypocomplementemic systemic lupus erythematosus. Clin. Exp. Immunol. 1972, 11:21-29.
74. Smith J.K., Chi D.S., Krish G., Reynolds S., Cambron G. Effect of exercise on complement activity. Ann. Allergy 1990, 65:304-310.
75. St-Pierre D.H., Cianflone K., Smith J., Coderre L., Karelis A.D., Imbeault P., Lavoie J.M., Rabasa-Lhoret R. Change in plasma acylation stimulating protein during euglycaemic-hyperinsulinaemic clamp in overweight and obese postmenopausal women: a MONET study. Clin. Endocrinol. (Oxf.) 2009, 70:539-546.
76. Staiger K., Stefan N., Staiger H., Brendel M.D., Brandhorst D., Bretzel R.G., Machicao F., Kellerer M., Stumvoll M., Fritsche A., Haring H.U. Adiponectin is functionally active in human islets but does not affect insulin secretory function or beta-cell lipoapoptosis. J. Clin. Endocrinol. Metab. 2005, 90:6707-6713.
77. Strey C.W., Markiewski M., Mastellos D., Tudoran R., Spruce L.A., Greenbaum L.E., Lambris J.D. The proinflammatory mediators C3a and C5a are essential for liver regeneration. J. Exp. Med. 2003, 198:913-923.
78. Tao Y., Cianflone K., Sniderman A.D., Colby-Germinario S.P., Germinario R.J. Acylation-stimulating protein (ASP) regulates glucose transport in the rat L6 muscle cell line. Biochim. Biophys. Acta 1997, 1344:221-229.
79. Tom F.Q., Gauvreau D., Lapointe M., Lu H., Poursharifi P., Luo X.P., Cianflone K. Differential chemoattractant response in adipocytes and macrophages to the action of acylation stimulating protein. Eur. J. Cell Biol. 2013, 92:61-69.
80. Vaisar T., Pennathur S., Green P.S., Gharib S.A., Hoofnagle A.N., Cheung M.C., Byun J., Vuletic S., Kassim S., Singh P., Chea H., Knopp R.H., Brunzell J., Geary R., Chait A., Zhao X.Q., Elkon K., Marcovina S., Ridker P., Oram J.F., Heinecke J.W. Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL. J. Clin. Invest. 2007, 117:746-756.
81. Wen Y., Wang H., MacLaren R., Wu J., Lu H., Cianflone K. Palmitate and oleate induction of acylation stimulating protein resistance in 3T3-L1 adipocytes and preadipocytes. J. Cell. Biochem. 2008, 104:391-401.
82. Weyer C., Pratley R.E. Fasting and postprandial plasma concentrations of acylation-stimulation protein (ASP) in lean and obese Pima Indians compared to Caucasians. Obes. Res. 1999, 7:444-452.
83. Winzell M.S., Nogueiras R., Dieguez C., Ahren B. Dual action of adiponectin on insulin secretion in insulin-resistant mice. Biochem. Biophys. Res. Commun. 2004, 321:154-160.
84. Xia Z., Stanhope K.L., Digitale E., Simion O.M., Chen L., Havel P., Cianflone K. Acylation-stimulating protein (ASP)/complement C3adesArg deficiency results in increased energy expenditure in mice. J. Biol. Chem. 2004, 279:4051-4057.
85. Xu R., Lin F., He J., Jin L., Zhang J.Y., Fu J., Liu H., Wang S., Zhang Z., Wang F.S. Complement 5a stimulates hepatic stellate cells in vitro, and is increased in the plasma of patients with chronic hepatitis B. Immunology 2013, 138:228-234.
86. Yan J., Vetvicka V., Xia Y., Hanikyrova M., Mayadas T.N., Ross G.D. Critical role of Kupffer cell CR3 (CD11b/CD18) in the clearance of IgM-opsonized erythrocytes or soluble beta-glucan. Immunopharmacology 2000, 46:39-54.
87. Yang Y., Lu H.L., Zhang J., Yu H.Y., Wang H.W., Zhang M.X., Cianflone K. Relationships among acylation stimulating protein, adiponectin and complement C3 in lean vs obese type 2 diabetes. Int. J. Obes. 2006, 30:439-446.
88. Yasruel Z., Cianflone K., Sniderman A.D., Rosenbloom M., Walsh M., Rodriguez M.A. Effect of acylation stimulating protein on the triacylglycerol synthetic pathway of human adipose tissue. Lipids 1991, 26:495-499.
89. Yesilova Z., Ozata M., Oktenli C., Bagci S., Ozcan A., Sanisoglu S.Y., Uygun A., Yaman H., Karaeren N., Dagalp K. Increased acylation stimulating protein concentrations in nonalcoholic fatty liver disease are associated with insulin resistance. Am. J. Gastroenterol. 2005, 100:842-849.
90. Zhou X., Fukuda N., Matsuda H., Endo M., Wang X., Saito K., Ueno T., Matsumoto T., Matsumoto K., Soma M., Kobayashi N., Nishiyama A. Complement 3 activates the renal renin-angiotensin system by induction of epithelial-to-mesenchymal transition of the nephrotubulus in mice. Am. J. Physiol. Renal Physiol. 2013, 305:F957-F967.